View All News

Reuters June 13, 20237:03 AM EDTUpdated 7 days ago Read full article at: https://www.reuters.com/business/healthcare-pharmaceuticals/childhood-vaccine-rates-show-signs-recovery-after-pandemic-backslide-gavi-2023-06-13/ LONDON, June 13 (Reuters) – Childhood immunisation rates began to recover last year in the world’s poorest countries after being badly hit by COVID-19 disruptions, according to the global vaccine alliance Gavi. Last year, 80% of children got their diptheria, tetanus […]

The Washington Post Read Full article at:https://www.washingtonpost.com/politics/2023/06/16/another-covid-booster-is-coming-how-many-will-get-it/ Analysis by Rachel Roubein with research by McKenzie Beard June 16, 2023 at 7:38 a.m. EDT A new coronavirus booster shot is likely coming this fall. In a unanimous vote yesterday, the Food and Drug Administration’s expert advisers issued their recommendation: The next round of coronavirus shots should target the XBB variants, a branch […]

AP News By LAURAN NEERGAARD and MIKE STOBBE, June 15, 2023 Read full article at: https://apnews.com/article/covid19-vaccine-booster-shot-coronavirus-fall-72c0436ac9211f1a893fe8056106909d The COVID-19 vaccines are on track for a big recipe change this fall. Today’s vaccines still contain the original coronavirus strain, the one that started the pandemic — even though that was long ago supplanted by mutated versions as […]

The New York Times (5/5, Nolen) reported that on Friday, the World Health Organization (WHO) announced “that it was ending the emergency it declared for COVID-19 more than three years ago,” although “WHO officials warned that the decision to lift the emergency does not signal an end to the pandemic, and cautioned countries not take […]

USA Today (May 5th) – A new study may partly explain what’s driving rare cases of heart inflammation, called myocarditis, in some young people who have gotten repeat doses of the mRNA COVID-19 vaccines. The risk of developing vaccine-related myocarditis is extremely low, affecting fewer than 20 people per 1,000,000 vaccinations, according to the National Institutes […]

On May 3, the Food and Drug Administration (FDA) approved the first respiratory syncytial virus (RSV) vaccine for use in the U.S. FDA approved the drug, Arexvy from GSK, for prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age or older. RSV is a highly contagious virus that is […]

AMA (May 5th, 2023) – Federal officials are recommending a spring booster dose of the updated bivalent SARS-CoV-2 vaccine for certain types of patients. But who should get it and when? Eligibility applies to adults 65 or older, as well as adults and children with immunocompromising conditions, according to AMA Board Chair Sandra Adamson Fryhofer, MD. […]

The Hill (4/18/23) – The Food and Drug Administration (FDA) on Tuesday announced it was simplifying its recommended COVID-19 vaccine schedule, stating a single dose of the bivalent vaccine specific to the BA.4 and BA.5 strains of the omicron variant is enough for most individuals. Going forward, the FDA announced all coronavirus vaccines administered to […]

ABC News (4/18/23) – The Food and Drug Administration authorized a second omicron-targeted bivalent COVID-19 booster vaccine for people over 65 or who are immunocompromised, the agency announced Tuesday. The agency also said any adult who has not yet been vaccinated will get one dose of an updated bivalent shot, rather than starting with the original […]

The Washington Post (4/18, McGinley, Sun) reports that the FDA “cleared the way for people who are at least 65 years old or immune-compromised to receive a second updated booster shot against the coronavirus, an option designed to bolster protection for the most vulnerable Americans even as the pandemic recedes.” This “bivalent booster…targets Omicron subvariants […]